China SXT Pharmaceuticals (SXTC) Current Taxes (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Current Taxes for 9 consecutive years, with $2871.0 the latest figure, recorded in Q1 2026.

• Quarterly Current Taxes fell 99.72% year-over-year to $2871.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2871.0 (down 99.72% YoY) and the FY2026 annual result came in at $2871.0, down 99.72% from the prior year.
• Current Taxes eased to $2871.0 in Q1 2026 per SXTC's latest filing, from $1.0 million in the prior quarter.
• Over the last five years, Current Taxes for SXTC reached as high as $1.2 million in Q1 2022 and fell as low as $2871.0 in Q1 2026.
• A 5-year average of $955772.7 and a median of $1.1 million in 2024 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2024 — Current Taxes climbed 5.42% — and 2026, when it plunged 99.72%.
• Year by year, Current Taxes stood at $1.1 million in 2022, then retreated by 3.11% to $1.0 million in 2023, then increased by 5.42% to $1.1 million in 2024, then decreased by 5.17% to $1.0 million in 2025, then tumbled by 99.72% to $2871.0 in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered $2871.0, $1.0 million, and $1.0 million for Q1 2026, Q3 2025, and Q1 2025 respectively.